UAB 1846: A Phase 2 Study of Olaparib Monotherapy in Metastatic Breast Cancer Patients with Germline or Somatic Mutations in DNA Repair Genes

Grant

Date/time Interval

  • August 5, 2019 - December 18, 2023
  • Total Award Amount

  • 129461.00
  • Direct Costs

  • 99585.00
  • Sponsor Award Id

  • Contributor

  • Eddy Yang M.D., Ph.D.   Principal Investigator